Topiramate induced bilateral angle-closure glaucoma: low dosage in a short time.

Objective: The aim of this article is to create awareness among medical colleagues regarding the severe ophthalmic side effects associated with topiramate use.

Methods: A case of severe acute bilateral angle closure glaucoma with visual blurring after oral topiramate therapy.

Results: This case was successfully managed by discontinuing topiramate and by starting anti-glaucoma medication. Intraocular pressure, acute transient myopia, and anterior chamber depth were normalized.

Conclusions: It is important for clinicians to recognize these conditions and educate patients about these serious adverse effects when prescribing topiramate.